PTK-SMA2

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePTK-SMA2
Drug Alias Namespinal muscular atrophy therapy (Paratek)tetracycline (Paratek)Tetracycline Derivatives (Paratek)PTK-SMA2
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsSurvival motor neuron protein stimulants
TargetsSurvival motor neuron protein
Therapy Area/IndicationsMuscular Atrophy, Spinal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParatek Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParatek Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMuscular Atrophy, Spinal

Other Information

ATC CodeN/A
Related LinksN/A